Condition
Heritable Pulmonary Arterial Hypertension
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting3
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05584722Recruiting
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
NCT01884051Recruiting
Hormonal, Metabolic, and Signaling Interactions in PAH
NCT05462574Recruiting
Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)
NCT03069716Not ApplicableCompleted
A Mobile Health Intervention in Pulmonary Arterial Hypertension
NCT03933579Unknown
The PAH Platform for Deep Phenotyping in Korean Subjects
Showing all 5 trials